[PHARMA] QoQ TTM Result on 30-Jun-2021 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-Aug-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Jun-2021 [#2]
Profit Trend
QoQ- 13.2%
YoY- 121.92%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 4,983,690 4,815,015 4,737,880 3,230,009 2,698,649 2,725,071 2,806,171 46.70%
PBT 282,990 277,075 138,481 44,355 36,437 35,793 -189,175 -
Tax -104,757 -104,870 -58,488 -13,392 -9,755 -9,524 43,758 -
NP 178,233 172,205 79,993 30,963 26,682 26,269 -145,417 -
-
NP to SH 176,748 172,150 80,344 31,951 28,226 27,489 -144,778 -
-
Tax Rate 37.02% 37.85% 42.24% 30.19% 26.77% 26.61% - -
Total Cost 4,805,457 4,642,810 4,657,887 3,199,046 2,671,967 2,698,802 2,951,588 38.43%
-
Net Worth 413,947 450,411 391,428 357,275 355,919 337,298 345,040 12.91%
Dividend
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Div 121,759 121,748 58,895 36,634 23,534 28,740 26,125 179.27%
Div Payout % 68.89% 70.72% 73.30% 114.66% 83.38% 104.55% 0.00% -
Equity
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Net Worth 413,947 450,411 391,428 357,275 355,919 337,298 345,040 12.91%
NOSH 1,309,126 1,309,126 1,309,126 261,991 261,705 261,705 261,705 192.77%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin 3.58% 3.58% 1.69% 0.96% 0.99% 0.96% -5.18% -
ROE 42.70% 38.22% 20.53% 8.94% 7.93% 8.15% -41.96% -
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 380.45 367.74 361.91 246.81 1,031.18 1,042.20 1,073.54 -49.95%
EPS 13.49 13.15 6.14 2.44 10.79 10.51 -55.39 -
DPS 9.30 9.30 4.50 2.80 9.00 11.00 10.00 -4.72%
NAPS 0.316 0.344 0.299 0.273 1.36 1.29 1.32 -61.47%
Adjusted Per Share Value based on latest NOSH - 261,991
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 345.79 334.09 328.74 224.11 187.25 189.08 194.71 46.70%
EPS 12.26 11.94 5.57 2.22 1.96 1.91 -10.05 -
DPS 8.45 8.45 4.09 2.54 1.63 1.99 1.81 179.59%
NAPS 0.2872 0.3125 0.2716 0.2479 0.247 0.234 0.2394 12.91%
Price Multiplier on Financial Quarter End Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 -
Price 0.755 0.74 0.835 5.29 3.26 5.00 4.32 -
P/RPS 0.20 0.20 0.23 2.14 0.32 0.48 0.40 -37.03%
P/EPS 5.60 5.63 13.61 216.68 30.23 47.56 -7.80 -
EY 17.87 17.77 7.35 0.46 3.31 2.10 -12.82 -
DY 12.32 12.57 5.39 0.53 2.76 2.20 2.31 205.56%
P/NAPS 2.39 2.15 2.79 19.38 2.40 3.88 3.27 -18.87%
Price Multiplier on Announcement Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 20/05/22 17/02/22 19/11/21 20/08/21 21/05/21 17/03/21 19/11/20 -
Price 0.72 0.76 0.845 0.925 4.03 3.49 5.72 -
P/RPS 0.19 0.21 0.23 0.37 0.39 0.33 0.53 -49.56%
P/EPS 5.34 5.78 13.77 37.89 37.37 33.20 -10.33 -
EY 18.74 17.30 7.26 2.64 2.68 3.01 -9.68 -
DY 12.92 12.23 5.32 3.03 2.23 3.15 1.75 279.61%
P/NAPS 2.28 2.21 2.83 3.39 2.96 2.71 4.33 -34.81%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment